Sai Life Sciences, today announced the appointment of Dr. Dean Edney as Senior Vice President and Global Head of Process […]
Advancing 3D Hepatic Spheroid-Array Approach for Hepatic Clearance Assessment
18 Aug 2026
A recent publication from Sai Life Sciences highlights our work on a three-dimensional hepatic spheroid-array system for the assessment of hepatic clearance of small molecules and beyond-rule-of-five (bRo5) compounds, including PROTACs.
The study demonstrates how the 3D hepatic spheroid-array system provides a more physiologically relevant approach to predicting hepatic clearance, enabling improved characterization of metabolically stable compounds that are often challenging to assess using conventional suspension hepatocyte models.
As part of our broader focus on New Approach Methodologies (NAMs), we continue to advance physiologically relevant strategies that help answer increasingly complex ADME questions and support informed decision-making in drug discovery and development.
The article was authored by Viraj Mehta, Rupa Yellanki, Parusharamulu Molgara, Venkatesham Uthukam, Prabhakara Reddy Kolli, Tarun Sharma, Vamsi Madgula and Guruswamy Karnam.
Read the publication: https://dmd.aspetjournals.org/article/S0090-9556(26)00634-3/abstract
Related News
Sai Life Sciences will be in New York City for DCAT Week 2020 during March 23-26, 2020. Meet us to […]
10 Feb 2020
Sai Life Sciences has initiated the recruitment of 300+ scientists for its upcoming integrated Research & Technology (R&T) centre in […]